CA2244862A1 - Substituted amide derivatives - Google Patents
Substituted amide derivativesInfo
- Publication number
- CA2244862A1 CA2244862A1 CA002244862A CA2244862A CA2244862A1 CA 2244862 A1 CA2244862 A1 CA 2244862A1 CA 002244862 A CA002244862 A CA 002244862A CA 2244862 A CA2244862 A CA 2244862A CA 2244862 A1 CA2244862 A1 CA 2244862A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- represented
- lower alkyl
- atom
- oxygen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention relates to a compound represented by general formula (I) or a pharmaceutically acceptable salt or ester thereof:
(see formula I) (wherein each of (see formula II) is an aryl group or an aromatic heterocyclic group; A1 is a C1-6 chain hydrocarbon group or a group represented by -A1a-W1-A1b- (wherein W1 is an oxygen atom, a sulfur atom, an ethynylene group, a cyclopropylene group or a group represented by -NR w-); A2 is a C1-8 chain hydrocarbon group; R1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a group represented by R a COO-(wherein R a is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or by R b CONR c- (wherein R b is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or an alicyclic group; R2 is a lower alkyl group; and each of X and Y is an oxygen atom, a sulfur atom, a carbonyl group, a group represented by -CHR d- or by -NR e-, or X and Y together represent a vinylene group or an ethynylene group, provided that when one of X and Y is an oxygen atom, a sulfur atom or group represented by -NR e-, the other is a carbonyl group or a group represented by -CHR d-] and an antitumor agent comprising it as an active ingredient.
(see formula I) (wherein each of (see formula II) is an aryl group or an aromatic heterocyclic group; A1 is a C1-6 chain hydrocarbon group or a group represented by -A1a-W1-A1b- (wherein W1 is an oxygen atom, a sulfur atom, an ethynylene group, a cyclopropylene group or a group represented by -NR w-); A2 is a C1-8 chain hydrocarbon group; R1 is a lower alkyl group, a lower alkenyl group, a lower alkoxy group, a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a group represented by R a COO-(wherein R a is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or by R b CONR c- (wherein R b is a hydrogen atom, an amino group, a lower alkyl group, a lower alkoxy group or a lower alkylamino group) or an alicyclic group; R2 is a lower alkyl group; and each of X and Y is an oxygen atom, a sulfur atom, a carbonyl group, a group represented by -CHR d- or by -NR e-, or X and Y together represent a vinylene group or an ethynylene group, provided that when one of X and Y is an oxygen atom, a sulfur atom or group represented by -NR e-, the other is a carbonyl group or a group represented by -CHR d-] and an antitumor agent comprising it as an active ingredient.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4550296 | 1996-02-07 | ||
JP8/45502 | 1996-02-07 | ||
PCT/JP1997/000304 WO1997029073A1 (en) | 1996-02-07 | 1997-02-07 | Substituted amide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2244862A1 true CA2244862A1 (en) | 1997-08-14 |
CA2244862C CA2244862C (en) | 2006-03-28 |
Family
ID=36123391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002244862A Expired - Fee Related CA2244862C (en) | 1996-02-07 | 1997-02-07 | Substituted amide derivatives |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2244862C (en) |
-
1997
- 1997-02-07 CA CA002244862A patent/CA2244862C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2244862C (en) | 2006-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3192395A (en) | Substituted amide derivative | |
EP0805154A4 (en) | ||
CA2277947A1 (en) | Pyrrolidine derivatives having phospholipase a2 inhibitory activity | |
DK0819125T3 (en) | Thienyl, furyl, pyrrolyl and biphenylsulfonamides and derivatives thereof which modulate the activity of endothelin | |
WO2003043992A1 (en) | 4-oxoquinoline derivatives | |
EP1026149A4 (en) | Amidocarboxylic acid derivatives | |
CA2102591A1 (en) | Hypoglycemic Agent | |
CA2088798A1 (en) | Condensed imidazopyridine derivatives | |
EP0882714A4 (en) | Substituted vinylpyridine derivatives and drugs containing the same | |
CA2129542A1 (en) | Pharmaceutical preparation based on rhamnolipid | |
EP0786252A4 (en) | Antitumor agent | |
CA2244862A1 (en) | Substituted amide derivatives | |
CA2487033A1 (en) | Amide substituted xanthine derivatives with gluconeogenesis modulating activity | |
AU1619297A (en) | Substituted amide derivatives | |
AU8226891A (en) | Benzopyran derivative, production thereof, and pharmaceutical composition containing the same | |
AU1890299A (en) | Potassium channel activators | |
EP1142868A4 (en) | Amide derivatives | |
WO1997029077A1 (en) | Substituted amide derivatives | |
CA2244695A1 (en) | Cyclic amic acid derivatives | |
WO1997029074A1 (en) | N,n-disubstituted amic acid derivatives | |
EP0685461A4 (en) | 5-aminoacetylaminosulfonanilide compound. | |
CA2236851A1 (en) | Substituted vinylpyridine derivatives and drugs containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |